vs

Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and CaliberCos Inc. (CWD). Click either name above to swap in a different company.

CRYO CELL INTERNATIONAL INC is the larger business by last-quarter revenue ($7.8M vs $4.1M, roughly 1.9× CaliberCos Inc.). CRYO CELL INTERNATIONAL INC runs the higher net margin — -48.7% vs -188.3%, a 139.6% gap on every dollar of revenue. On growth, CRYO CELL INTERNATIONAL INC posted the faster year-over-year revenue change (-2.3% vs -52.5%). Over the past eight quarters, CRYO CELL INTERNATIONAL INC's revenue compounded faster (-0.1% CAGR vs -57.6%).

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

CaliberCos Inc. is a U.S.-headquartered alternative asset management firm focused primarily on real estate investments. It offers a diverse suite of investment vehicles covering commercial, residential, and industrial real estate assets, serving institutional investors, high-net-worth individuals, and retail clients across North America. It also delivers asset management, property operation, and value-add real estate development services to support consistent long-term returns for investors.

CCEL vs CWD — Head-to-Head

Bigger by revenue
CCEL
CCEL
1.9× larger
CCEL
$7.8M
$4.1M
CWD
Growing faster (revenue YoY)
CCEL
CCEL
+50.2% gap
CCEL
-2.3%
-52.5%
CWD
Higher net margin
CCEL
CCEL
139.6% more per $
CCEL
-48.7%
-188.3%
CWD
Faster 2-yr revenue CAGR
CCEL
CCEL
Annualised
CCEL
-0.1%
-57.6%
CWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCEL
CCEL
CWD
CWD
Revenue
$7.8M
$4.1M
Net Profit
$-3.8M
$-7.7M
Gross Margin
77.9%
Operating Margin
-50.6%
-196.6%
Net Margin
-48.7%
-188.3%
Revenue YoY
-2.3%
-52.5%
Net Profit YoY
-105.1%
32.2%
EPS (diluted)
$-0.46
$1.95

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCEL
CCEL
CWD
CWD
Q4 25
$7.8M
$4.1M
Q3 25
$7.8M
$3.6M
Q2 25
$7.9M
$5.1M
Q1 25
$8.0M
$7.3M
Q4 24
$8.0M
$8.7M
Q3 24
$8.1M
$11.3M
Q2 24
$8.0M
$8.2M
Q1 24
$7.9M
$23.0M
Net Profit
CCEL
CCEL
CWD
CWD
Q4 25
$-3.8M
$-7.7M
Q3 25
$749.4K
$-4.4M
Q2 25
$355.8K
$-5.3M
Q1 25
$282.9K
$-4.4M
Q4 24
$-1.9M
$-11.4M
Q3 24
$1.1M
$146.0K
Q2 24
$655.8K
$-4.7M
Q1 24
$556.2K
$-3.8M
Gross Margin
CCEL
CCEL
CWD
CWD
Q4 25
77.9%
Q3 25
77.0%
Q2 25
76.6%
Q1 25
75.1%
Q4 24
78.4%
Q3 24
73.6%
Q2 24
74.8%
Q1 24
73.7%
Operating Margin
CCEL
CCEL
CWD
CWD
Q4 25
-50.6%
-196.6%
Q3 25
24.3%
-129.6%
Q2 25
18.8%
-112.4%
Q1 25
13.3%
-62.7%
Q4 24
-1.5%
-236.8%
Q3 24
17.2%
0.0%
Q2 24
17.3%
-65.0%
Q1 24
10.5%
-22.9%
Net Margin
CCEL
CCEL
CWD
CWD
Q4 25
-48.7%
-188.3%
Q3 25
9.6%
-120.2%
Q2 25
4.5%
-104.5%
Q1 25
3.5%
-60.7%
Q4 24
-23.2%
-247.6%
Q3 24
13.0%
1.3%
Q2 24
8.2%
-57.8%
Q1 24
7.1%
-16.6%
EPS (diluted)
CCEL
CCEL
CWD
CWD
Q4 25
$-0.46
$1.95
Q3 25
$0.09
$-1.65
Q2 25
$0.04
$-4.15
Q1 25
$0.03
$-3.85
Q4 24
$-0.23
$-10.15
Q3 24
$0.13
$0.12
Q2 24
$0.08
$-4.34
Q1 24
$0.07
$-3.53

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCEL
CCEL
CWD
CWD
Cash + ST InvestmentsLiquidity on hand
$3.3M
$2.9M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$-18.6M
$1.3M
Total Assets
$61.7M
$135.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCEL
CCEL
CWD
CWD
Q4 25
$3.3M
$2.9M
Q3 25
$3.2M
$10.9M
Q2 25
$4.4M
$683.0K
Q1 25
$3.5M
$1.6M
Q4 24
$3.5M
$2.3M
Q3 24
$2.1M
$1.6M
Q2 24
$1.5M
$1.8M
Q1 24
$979.6K
$2.1M
Total Debt
CCEL
CCEL
CWD
CWD
Q4 25
$8.4M
Q3 25
$8.4M
Q2 25
$8.4M
Q1 25
$8.5M
Q4 24
$8.5M
Q3 24
$8.5M
Q2 24
$8.5M
Q1 24
$8.6M
Stockholders' Equity
CCEL
CCEL
CWD
CWD
Q4 25
$-18.6M
$1.3M
Q3 25
$-14.8M
$4.2M
Q2 25
$-15.6M
$-19.9M
Q1 25
$-14.7M
$-15.8M
Q4 24
$-13.2M
$-12.6M
Q3 24
$-9.6M
$-3.8M
Q2 24
$-10.7M
$-4.7M
Q1 24
$-10.3M
$-745.0K
Total Assets
CCEL
CCEL
CWD
CWD
Q4 25
$61.7M
$135.4M
Q3 25
$63.2M
$82.6M
Q2 25
$64.4M
$59.3M
Q1 25
$64.4M
$103.6M
Q4 24
$64.7M
$105.5M
Q3 24
$62.9M
$158.6M
Q2 24
$62.6M
$195.2M
Q1 24
$61.7M
$201.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCEL
CCEL
CWD
CWD
Operating Cash FlowLast quarter
$1.3M
$-12.1M
Free Cash FlowOCF − Capex
$1.2M
FCF MarginFCF / Revenue
15.5%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$5.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCEL
CCEL
CWD
CWD
Q4 25
$1.3M
$-12.1M
Q3 25
$2.5M
$-4.6M
Q2 25
$707.0K
$-1.2M
Q1 25
$954.1K
$-1.7M
Q4 24
$2.2M
$555.0K
Q3 24
$2.4M
$-74.0K
Q2 24
$1.8M
$1.4M
Q1 24
$-356.9K
$-1.5M
Free Cash Flow
CCEL
CCEL
CWD
CWD
Q4 25
$1.2M
Q3 25
$2.5M
Q2 25
$644.6K
Q1 25
$892.0K
Q4 24
$2.1M
Q3 24
$2.3M
Q2 24
$21.5K
Q1 24
$-814.6K
FCF Margin
CCEL
CCEL
CWD
CWD
Q4 25
15.5%
Q3 25
31.9%
Q2 25
8.1%
Q1 25
11.2%
Q4 24
26.8%
Q3 24
27.9%
Q2 24
0.3%
Q1 24
-10.4%
Capex Intensity
CCEL
CCEL
CWD
CWD
Q4 25
0.9%
Q3 25
0.5%
Q2 25
0.8%
Q1 25
0.8%
Q4 24
0.1%
Q3 24
2.3%
Q2 24
21.8%
Q1 24
5.8%
Cash Conversion
CCEL
CCEL
CWD
CWD
Q4 25
Q3 25
3.38×
Q2 25
1.99×
Q1 25
3.37×
Q4 24
Q3 24
2.32×
-0.51×
Q2 24
2.70×
Q1 24
-0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons